questionsmedicales.fr
Maladies de l'appareil digestif
Maladies du foie
Insuffisance hépatique
Défaillance hépatique
Défaillance hépatique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Défaillance hépatique : Questions médicales les plus fréquentes",
"headline": "Défaillance hépatique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Défaillance hépatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Défaillance hépatique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Insuffisance hépatique",
"url": "https://questionsmedicales.fr/mesh/D048550",
"about": {
"@type": "MedicalCondition",
"name": "Insuffisance hépatique",
"code": {
"@type": "MedicalCode",
"code": "D048550",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie du foie en phase terminale",
"alternateName": "End Stage Liver Disease",
"url": "https://questionsmedicales.fr/mesh/D058625",
"about": {
"@type": "MedicalCondition",
"name": "Maladie du foie en phase terminale",
"code": {
"@type": "MedicalCode",
"code": "D058625",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.177"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Défaillance hépatique aigüe",
"alternateName": "Liver Failure, Acute",
"url": "https://questionsmedicales.fr/mesh/D017114",
"about": {
"@type": "MedicalCondition",
"name": "Défaillance hépatique aigüe",
"code": {
"@type": "MedicalCode",
"code": "D017114",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Insuffisance hépatique aigüe sur chronique",
"alternateName": "Acute-On-Chronic Liver Failure",
"url": "https://questionsmedicales.fr/mesh/D065290",
"about": {
"@type": "MedicalCondition",
"name": "Insuffisance hépatique aigüe sur chronique",
"code": {
"@type": "MedicalCode",
"code": "D065290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.750.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nécrose hépatique massive",
"alternateName": "Massive Hepatic Necrosis",
"url": "https://questionsmedicales.fr/mesh/D047508",
"about": {
"@type": "MedicalCondition",
"name": "Nécrose hépatique massive",
"code": {
"@type": "MedicalCode",
"code": "D047508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.750.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Défaillance hépatique",
"alternateName": "Liver Failure",
"code": {
"@type": "MedicalCode",
"code": "D017093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "William Bernal",
"url": "https://questionsmedicales.fr/author/William%20Bernal",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Anand V Kulkarni",
"url": "https://questionsmedicales.fr/author/Anand%20V%20Kulkarni",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India."
}
},
{
"@type": "Person",
"name": "William M Lee",
"url": "https://questionsmedicales.fr/author/William%20M%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Digestive and Liver Diseases Division, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA. Electronic address: william.lee@utsouthwestern.edu."
}
},
{
"@type": "Person",
"name": "Constantine J Karvellas",
"url": "https://questionsmedicales.fr/author/Constantine%20J%20Karvellas",
"affiliation": {
"@type": "Organization",
"name": "Division of Gastroenterology (Liver Unit), Division of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du foie",
"item": "https://questionsmedicales.fr/mesh/D008107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Insuffisance hépatique",
"item": "https://questionsmedicales.fr/mesh/D048550"
},
{
"@type": "ListItem",
"position": 5,
"name": "Défaillance hépatique",
"item": "https://questionsmedicales.fr/mesh/D017093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Défaillance hépatique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Défaillance hépatique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Défaillance hépatique",
"description": "Comment diagnostiquer une défaillance hépatique ?\nQuels tests sont utilisés pour évaluer le foie ?\nQuels signes cliniques indiquent une défaillance hépatique ?\nL'échographie est-elle utile pour le diagnostic ?\nQuand faut-il envisager une biopsie hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Défaillance hépatique",
"description": "Quels sont les symptômes courants de la défaillance hépatique ?\nLa confusion mentale est-elle un symptôme ?\nComment l'ascite se manifeste-t-elle ?\nLes saignements sont-ils fréquents ?\nLes démangeaisons sont-elles liées à la défaillance hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Défaillance hépatique",
"description": "Comment prévenir la défaillance hépatique ?\nL'alimentation joue-t-elle un rôle ?\nLes vaccinations sont-elles importantes ?\nComment éviter les toxines ?\nLe contrôle du poids est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Défaillance hépatique",
"description": "Quels traitements sont disponibles pour la défaillance hépatique ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une transplantation hépatique ?\nY a-t-il des traitements pour l'ascite ?\nComment gérer la confusion mentale ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Défaillance hépatique",
"description": "Quelles sont les complications de la défaillance hépatique ?\nL'encéphalopathie hépatique est-elle grave ?\nComment l'hémorragie se produit-elle ?\nLes infections sont-elles fréquentes ?\nQu'est-ce que le syndrome hépatopulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Défaillance hépatique",
"description": "Quels sont les principaux facteurs de risque ?\nL'hépatite C augmente-t-elle le risque ?\nLe diabète est-il un facteur de risque ?\nL'obésité influence-t-elle la santé du foie ?\nLes médicaments peuvent-ils être un risque ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une défaillance hépatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des examens d'imagerie et l'évaluation des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le foie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les transaminases, la bilirubine et l'albumine dans le sang."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une défaillance hépatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent l'ictère, l'ascite, la confusion et la fatigue extrême."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie aide à visualiser les anomalies du foie et à évaluer sa taille."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une biopsie hépatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie est envisagée si les tests ne déterminent pas la cause de la défaillance."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la défaillance hépatique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la jaunisse, la fatigue, des démangeaisons et des nausées."
}
},
{
"@type": "Question",
"name": "La confusion mentale est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la confusion peut survenir en raison de l'accumulation de toxines dans le sang."
}
},
{
"@type": "Question",
"name": "Comment l'ascite se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ascite se manifeste par un gonflement abdominal dû à l'accumulation de liquide."
}
},
{
"@type": "Question",
"name": "Les saignements sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements peuvent survenir en raison de la coagulation altérée."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles liées à la défaillance hépatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons peuvent être causées par l'accumulation de sels biliaires dans le sang."
}
},
{
"@type": "Question",
"name": "Comment prévenir la défaillance hépatique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, l'évitement de l'alcool et la vaccination contre l'hépatite."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée et riche en nutriments peut soutenir la santé du foie."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se faire vacciner contre l'hépatite A et B peut prévenir des infections hépatiques."
}
},
{
"@type": "Question",
"name": "Comment éviter les toxines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez l'exposition aux produits chimiques nocifs et aux médicaments non prescrits."
}
},
{
"@type": "Question",
"name": "Le contrôle du poids est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé réduit le risque de maladies hépatiques et de défaillance."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la défaillance hépatique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la gestion des symptômes, les médicaments et, dans certains cas, la transplantation hépatique."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent traiter les causes sous-jacentes et soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand envisager une transplantation hépatique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transplantation est envisagée lorsque le foie est gravement endommagé et ne peut pas récupérer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements pour l'ascite ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des diurétiques et des procédures de drainage peuvent être utilisés pour traiter l'ascite."
}
},
{
"@type": "Question",
"name": "Comment gérer la confusion mentale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'élimination des toxines et le traitement des causes sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la défaillance hépatique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'encéphalopathie, l'hémorragie et l'infection."
}
},
{
"@type": "Question",
"name": "L'encéphalopathie hépatique est-elle grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles neurologiques sévères et nécessite une attention médicale."
}
},
{
"@type": "Question",
"name": "Comment l'hémorragie se produit-elle ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémorragie peut survenir en raison de la coagulation altérée et de la rupture de varices."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent développer des infections en raison d'une immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le syndrome hépatopulmonaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une complication rare où le foie affecte la fonction pulmonaire, entraînant des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'alcoolisme, l'hépatite virale, l'obésité et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "L'hépatite C augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite C est un facteur de risque majeur pour le développement de la défaillance hépatique."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque de maladies hépatiques et de défaillance hépatique."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle la santé du foie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est liée à la stéatose hépatique et à un risque accru de défaillance."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent endommager le foie et augmenter le risque de défaillance."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...